RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $108

Benzinga Newsdesk www.benzinga.com Positive 92.2%

Neg 0% Neu 0% Pos 92.2%

RBC Capital analyst Ryan Halsted maintains HealthEquity (NASDAQ:HQY) with a Outperform and raises the price target from $100 to $108.